Boron–Oxygen Chelation‐Enabled Aza‐BODIPY J ‐Aggregates: NIR‐II Imaging and Photothermal Therapy for Single‐Dose Tumor Ablation
Small · 2025-09 · 21 (35)
DOI: 10.1002/smll.202504607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 04.07.2025. Verfasst von Yanlu Yu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Te…. Hauptthemen laut MEDLINE: Boron Compounds, Photothermal Therapy, Oxygen, Boron. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: Zhejiang Provincial Natural Science Foundation of China, National Natural Science Foundation of China, Interdisciplinary Research Project of Hangzhou Normal University.
Abstract (Originalsprache)
Integrating high‐performance near‐infrared‐II (NIR‐II, 900–1880 nm) fluorescence imaging with efficient photothermal therapy (PTT) in a single nanoplatform remains a formidable challenge in cancer theranostics. Herein, a supramolecular engineering strategy leveraging boron–oxygen (B–O) chelation is presented to construct conformationally locked aza‐BODIPY derivatives (BTA‐BDP) that self‐assemble into ultrastable J ‐aggregates. This design achieves dual breakthroughs: 1) a fluorescence quantum yield ( Φ ) of 4.37% in the NIR‐II window ( λ em = 1014 nm), surpassing the typical Φ < 1% barrier for NIR‐II emitters; and 2) a record photothermal conversion efficiency (PCE) of 69.6%, exceeding most organic photothermal agents (PCE < 50%). Molecular dynamics simulations and pharmacokinetic studies reveal that the combination of strong π–π stacking interactions and long alkyl chains prolongs tumor retention (>344 h), enabling single‐dose administration. Under low‐power 808 nm irradiation (0.4 W cm − 2 ), BTA‐BDP nanoparticles (NPs) induce rapid hyperthermia (Δ T = 25.9 °C) and complete tumor ablation in murine models, validated by histopathology and multimodal imaging (NIR‐II/photoacoustic). This work resolves the fluorescence‐photothermal trade‐off and establishes a supramolecular blueprint for precision cancer nanomedicine, thereby bridging the gap between molecular engineering and clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Materials, Chemistry and Chemical Engineering, Ha…
- State Key Laboratory of Modern Optical Instrumentations, Centre for Optical and Electromagnetic Research, College of Optical Science and Engineering, International Research Center for Advanced Photonics, Zhejiang Univer…
ORCID-Profile: Shouchun Yin
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
- Interdisciplinary Research Project of Hangzhou Normal University
Zitieren
APA
Yu, Y., Wang, Y., Wu, B., Yu, Q., Ye, J., Chen, Y., Qian, J., Li, Y., & Yin, S. (2025). Boron–Oxygen Chelation‐Enabled Aza‐BODIPY J ‐Aggregates: NIR‐II Imaging and Photothermal Therapy for Single‐Dose Tumor Ablation. Small, 21(35). https://doi.org/10.1002/smll.202504607
Vancouver
Yu Y, Wang Y, Wu B, Yu Q, Ye J, Chen Y, et al. Boron–Oxygen Chelation‐Enabled Aza‐BODIPY J ‐Aggregates: NIR‐II Imaging and Photothermal Therapy for Single‐Dose Tumor Ablation. Small. 2025;21(35). doi:10.1002/smll.202504607
BibTeX
@article{Yu2025,
author = {Yu, Yanlu and Wang, Yanfen and Wu, Baixuan and Yu, Qiqi and Ye, Jingtao and Chen, Yaofeng and Qian, Jun and Li, Yang and Yin, Shouchun},
title = {Boron–Oxygen Chelation‐Enabled Aza‐BODIPY J ‐Aggregates: NIR‐II Imaging and Photothermal Therapy for Single‐Dose Tumor Ablation},
journal = {Small},
year = {2025},
volume = {21},
number = {35},
doi = {10.1002/smll.202504607}
}
EUVIMED